Radiotherapy, Immunotherapy and DNA Repair Inhibitors: a Winning Combination towards the Oncology of the Future – Business Wire (press release)
|
Radiotherapy, Immunotherapy and DNA Repair Inhibitors: a Winning Combination towards the Oncology of the Future
Business Wire (press release) Immunotherapy is undeniably a new weapon of choice against cancer. However, despite impressive results against some tumors, 80% of patients do not respond to these new therapeutic strategies, the most advanced of which are PD1 and PDL1 inhibitors. |
